$GALE Recent Headlines Top longs and shorts to w
Post# of 145145
Posted On: 01/08/2014 2:00:21 PM
$GALE Recent Headlines
Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck
Prognosticating 2014: Athersys Shares Will Continue To Climb 2:51 p.m. Jan. 7, 2014 - Seeking Alpha
Galena Biopharma rises as first patient enrolled in FBP study 8:10 a.m. Jan. 7, 2014 - Seeking Alpha
Galena Enrolls First Patient in GALE-301 Cancer Immunotherapy Phase 2 Clinical Trial in Ovarian Cancer 6:10 a.m. Jan. 7, 2014 - benzinga.com
Biotech Stocks Under $10 With Huge Upside Potential for 2014 7:39 a.m. Jan. 3, 2014 - 247WallSt.com
Galena Biopharma rallies, SA bull upbeat for 2014 3:02 p.m. Dec. 31, 2013 - Seeking Alpha
The Young And Restless Portfolio Update: Heading Into 2014 After A Fabulous 2013 10:07 a.m. Dec. 31, 2013 - Seeking Alpha
Galena Biopharma Inc. (GALE) Shares March Higher, Can It Continue? - Tale of the Tape 8:41 a.m. Dec. 31, 2013 - Zacks.com
Team Alpha Portfolio Updates: 2014 Could Be The Year Of The Dividend Champs 9:00 a.m. Dec. 30, 2013 - Seeking Alpha
Ten Top Stocks Trading Under $10 to Buy for Big 2014 Gains 6:12 a.m. Dec. 27, 2013 - 247WallSt.com
Team Alpha Portfolios For Retirement: When Is Enough, Enough? 6:41 a.m. Dec. 25, 2013 - Seeking Alpha
Investing In A Rising Interest Rate Environment 11:55 a.m. Dec. 23, 2013 - Seeking Alpha
Will Galena's Post-Holiday Charm Continue? 11:51 a.m. Dec. 19, 2013 - Seeking Alpha
Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock 10:12 a.m. Dec. 12, 2013 - TheStreet.com
3 Breast Cancer Drugs That Could Boost Your Portfolio 4:45 p.m. Dec. 11, 2013 - Seeking Alpha
Today's Dead Cat Bounce Stock: Galena Biopharma (GALE) 3:01 p.m. Dec. 11, 2013 - TheStreet.com
Can The Uptrend Continue for Galena Biopharma Inc. (GALE)? - Tale of the Tape 7:15 a.m. Dec. 10, 2013 - Zacks.com
4 Reasons Why Galena Biopharma Is Headed Higher 1:05 p.m. Dec. 4, 2013 - Wall St. Cheat Sheet
Perilous Reversal Stock: Galena Biopharma (GALE) 11:40 a.m. Dec. 3, 2013 - TheStreet.com
Galena rallies, article calls pipeline "rich" 11:31 a.m. Dec. 2, 2013 - Seeking Alpha
Biotech Stocks Partying Like It's 1999 7:00 a.m. Dec. 2, 2013 - TheStreet.com
Morning Buzzers: Facebook Inc, Galena Biopharma Inc, Plug Power Inc, Cell Therapeutics Inc, Advanced Micro Devices 10:50 a.m. Jan. 7, 2014 - ACCESSWIRE
Galena Biopharma Enrolls First Patient in GALE-301 (Folate Binding Protein (FBP)) Cancer Immunotherapy Phase 2 Clinical Trial in Ovarian Cancer 7:05 a.m. Jan. 7, 2014 - GlobeNewswire
Special Stocks Analysis: ImmunoCellular Therapeutics, Vodafone Group, BlackBerry Ltd, Galena Biopharma Inc 10:04 a.m. Dec. 24, 2013 - ACCESSWIRE
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Clinical Studies Updates, and Stock Price Movements - Research Report on Merck, Select Medical Holdings, Galena Biopharma, Dendreon, and Echo Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
TrendingWallStreet.com Begins Volume Coverage on FB, TC, OCZ, and GALE 12:21 a.m. Dec. 5, 2013 - ACCESSWIRE
Breakfast News: Hewlett-Packard Company, Alpha Natural Resources, Yahoo! Inc, Galena Biopharma 8:51 a.m. Dec. 4, 2013 - ACCESSWIRE
Corporate News, Acquisitions: Herbalife Ltd, 3D Systems Corporation, Federal National Mortgage Association, Galena Biopharma Inc, Oncomed Pharmaceuticals 8:44 a.m. Dec. 4, 2013 - PR Newswire
Galena Biopharma to Present at the Oppenheimer 24th Annual Healthcare Conference 7:05 a.m. Dec. 4, 2013 - GlobeNewswire
Healthcare Sector Announce Awards, Conference Participation, Partnerships, and Closure of Public Offering - Research Report on Regeneron, Alnylam, Galena Biopharma, Amedisys, and Aeterna Zentaris 8:00 a.m. Dec. 3, 2013 - PR Newswire
TrendingWallStreet.com Begins Volume Coverage on MYGN, FNMA, ABX, and GALE 12:26 a.m. Dec. 3, 2013 - ACCESSWIRE
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
Galena Biopharma to Present at the 25th Annual Piper Jaffray Healthcare Conference 7:05 a.m. Nov. 26, 2013 - GlobeNewswire
HIMX, GALE, INTC and NVGN added to NASDAQ Active Stock Watch List at GSR 10:16 a.m. Nov. 25, 2013 - ACCESSWIRE
Settlement Agreement, Presentation of Trial Results, and Stock Price Update - Research Report on Johnson & Johnson, Mettler-Toledo, Galena Biopharma, Dendreon, and Amedisys 8:00 a.m. Nov. 25, 2013 - PR Newswire
Quarterly Reports and Events - Research Report on Mettler-Toledo, Galena Biopharma, Achillion, Wright Medical, and OXiGENE 8:00 a.m. Nov. 15, 2013 - PR Newswire
ZLCS, CLRX, DSCO and GALE added to NASDAQ Active Stock Watch List at GSR 10:19 a.m. Nov. 11, 2013 - ACCESSWIRE
Galena Biopharma Announces Initial Results From the Folate Binding Protein Vaccine Phase 1 Trial at the Society for Immunotherapy of Cancer Conference 7:05 a.m. Nov. 11, 2013 - GlobeNewswire
Galena Biopharma Reports Third Quarter 2013 Results 4:35 p.m. Nov. 6, 2013 - GlobeNewswire
Closing of Over-Allotment Options, Receiving Orphan Drug Designations, Release of Clinical Data, and Obtaining Important Patents - Research Report on Galena, Zalicus, Infinity, Stemline and Insmed 8:00 a.m. Nov. 5, 2013 - PR Newswire
Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck
Prognosticating 2014: Athersys Shares Will Continue To Climb 2:51 p.m. Jan. 7, 2014 - Seeking Alpha
Galena Biopharma rises as first patient enrolled in FBP study 8:10 a.m. Jan. 7, 2014 - Seeking Alpha
Galena Enrolls First Patient in GALE-301 Cancer Immunotherapy Phase 2 Clinical Trial in Ovarian Cancer 6:10 a.m. Jan. 7, 2014 - benzinga.com
Biotech Stocks Under $10 With Huge Upside Potential for 2014 7:39 a.m. Jan. 3, 2014 - 247WallSt.com
Galena Biopharma rallies, SA bull upbeat for 2014 3:02 p.m. Dec. 31, 2013 - Seeking Alpha
The Young And Restless Portfolio Update: Heading Into 2014 After A Fabulous 2013 10:07 a.m. Dec. 31, 2013 - Seeking Alpha
Galena Biopharma Inc. (GALE) Shares March Higher, Can It Continue? - Tale of the Tape 8:41 a.m. Dec. 31, 2013 - Zacks.com
Team Alpha Portfolio Updates: 2014 Could Be The Year Of The Dividend Champs 9:00 a.m. Dec. 30, 2013 - Seeking Alpha
Ten Top Stocks Trading Under $10 to Buy for Big 2014 Gains 6:12 a.m. Dec. 27, 2013 - 247WallSt.com
Team Alpha Portfolios For Retirement: When Is Enough, Enough? 6:41 a.m. Dec. 25, 2013 - Seeking Alpha
Investing In A Rising Interest Rate Environment 11:55 a.m. Dec. 23, 2013 - Seeking Alpha
Will Galena's Post-Holiday Charm Continue? 11:51 a.m. Dec. 19, 2013 - Seeking Alpha
Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock 10:12 a.m. Dec. 12, 2013 - TheStreet.com
3 Breast Cancer Drugs That Could Boost Your Portfolio 4:45 p.m. Dec. 11, 2013 - Seeking Alpha
Today's Dead Cat Bounce Stock: Galena Biopharma (GALE) 3:01 p.m. Dec. 11, 2013 - TheStreet.com
Can The Uptrend Continue for Galena Biopharma Inc. (GALE)? - Tale of the Tape 7:15 a.m. Dec. 10, 2013 - Zacks.com
4 Reasons Why Galena Biopharma Is Headed Higher 1:05 p.m. Dec. 4, 2013 - Wall St. Cheat Sheet
Perilous Reversal Stock: Galena Biopharma (GALE) 11:40 a.m. Dec. 3, 2013 - TheStreet.com
Galena rallies, article calls pipeline "rich" 11:31 a.m. Dec. 2, 2013 - Seeking Alpha
Biotech Stocks Partying Like It's 1999 7:00 a.m. Dec. 2, 2013 - TheStreet.com
Morning Buzzers: Facebook Inc, Galena Biopharma Inc, Plug Power Inc, Cell Therapeutics Inc, Advanced Micro Devices 10:50 a.m. Jan. 7, 2014 - ACCESSWIRE
Galena Biopharma Enrolls First Patient in GALE-301 (Folate Binding Protein (FBP)) Cancer Immunotherapy Phase 2 Clinical Trial in Ovarian Cancer 7:05 a.m. Jan. 7, 2014 - GlobeNewswire
Special Stocks Analysis: ImmunoCellular Therapeutics, Vodafone Group, BlackBerry Ltd, Galena Biopharma Inc 10:04 a.m. Dec. 24, 2013 - ACCESSWIRE
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Clinical Studies Updates, and Stock Price Movements - Research Report on Merck, Select Medical Holdings, Galena Biopharma, Dendreon, and Echo Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
TrendingWallStreet.com Begins Volume Coverage on FB, TC, OCZ, and GALE 12:21 a.m. Dec. 5, 2013 - ACCESSWIRE
Breakfast News: Hewlett-Packard Company, Alpha Natural Resources, Yahoo! Inc, Galena Biopharma 8:51 a.m. Dec. 4, 2013 - ACCESSWIRE
Corporate News, Acquisitions: Herbalife Ltd, 3D Systems Corporation, Federal National Mortgage Association, Galena Biopharma Inc, Oncomed Pharmaceuticals 8:44 a.m. Dec. 4, 2013 - PR Newswire
Galena Biopharma to Present at the Oppenheimer 24th Annual Healthcare Conference 7:05 a.m. Dec. 4, 2013 - GlobeNewswire
Healthcare Sector Announce Awards, Conference Participation, Partnerships, and Closure of Public Offering - Research Report on Regeneron, Alnylam, Galena Biopharma, Amedisys, and Aeterna Zentaris 8:00 a.m. Dec. 3, 2013 - PR Newswire
TrendingWallStreet.com Begins Volume Coverage on MYGN, FNMA, ABX, and GALE 12:26 a.m. Dec. 3, 2013 - ACCESSWIRE
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
Galena Biopharma to Present at the 25th Annual Piper Jaffray Healthcare Conference 7:05 a.m. Nov. 26, 2013 - GlobeNewswire
HIMX, GALE, INTC and NVGN added to NASDAQ Active Stock Watch List at GSR 10:16 a.m. Nov. 25, 2013 - ACCESSWIRE
Settlement Agreement, Presentation of Trial Results, and Stock Price Update - Research Report on Johnson & Johnson, Mettler-Toledo, Galena Biopharma, Dendreon, and Amedisys 8:00 a.m. Nov. 25, 2013 - PR Newswire
Quarterly Reports and Events - Research Report on Mettler-Toledo, Galena Biopharma, Achillion, Wright Medical, and OXiGENE 8:00 a.m. Nov. 15, 2013 - PR Newswire
ZLCS, CLRX, DSCO and GALE added to NASDAQ Active Stock Watch List at GSR 10:19 a.m. Nov. 11, 2013 - ACCESSWIRE
Galena Biopharma Announces Initial Results From the Folate Binding Protein Vaccine Phase 1 Trial at the Society for Immunotherapy of Cancer Conference 7:05 a.m. Nov. 11, 2013 - GlobeNewswire
Galena Biopharma Reports Third Quarter 2013 Results 4:35 p.m. Nov. 6, 2013 - GlobeNewswire
Closing of Over-Allotment Options, Receiving Orphan Drug Designations, Release of Clinical Data, and Obtaining Important Patents - Research Report on Galena, Zalicus, Infinity, Stemline and Insmed 8:00 a.m. Nov. 5, 2013 - PR Newswire
(0)
(0)